KearneyPMWheltonMReynoldsK, et al.Global burden of hypertension: Analysis of worldwide data. Lancet2005; 365: 217–223.
2.
MillsKTBundyJDKellyTN, et al.Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation2016; 134: 441–450.
3.
Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet2017; 389: 37–55.
4.
LacklandDT. Racial differences in hypertension: Implications for high blood pressure management. Am J Med Sci2014; 348: 135–138.
5.
van LaerSDSnijderMBAgyemangC, et al.Ethnic differences in hypertension prevalence and contributing determinants – the HELIUS study. Eur J Prev Cardiol2018; 25: 1914–1922.
6.
SowersJRZemelMBZemelP, et al.Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension1988; 12: 485–490.
7.
SteinCMLangCCSinghI, et al.Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity. Hypertension2000; 36: 945–951.
8.
GuptaAKPoulterNRDobsonJ, et al.Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial. Am J Hypertens2010; 23: 1023–1030.
9.
BersaouiMBaldewSMCornelisN, et al.The effect of exercise training on blood pressure in African and Asian populations: A systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2020; 27: 457–472.
10.
WheltonPKCareyRMAronowWS, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation2018; 138: e426–e483.
11.
PiepoliMFHoesAWAgewallS, et al.2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.